XML 336 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Operating activities:      
Net income $ 48,429,000 $ 29,660,000 $ 9,106,000
Adjustments to reconcile net income to net cash provided by (used for) operating activities:      
Depreciation and amortization 41,947,000 41,924,000 28,153,000
Deferred income taxes and related valuation allowance (300,000) (1,969,000) (8,704,000)
Net loss (gain) on sale of real estate, investments and other (54,000) 136,000 (1,594,000)
Stock-based compensation 10,425,000 11,246,000 8,022,000
Amortization of deferred financing costs 1,721,000 1,703,000 2,646,000
Unrealized Gain (Loss) on Derivatives (438,000) 853,000 0
Payment for Debt Extinguishment or Debt Prepayment Cost 0 14,803,000 0
Pension Expense (Reversal of Expense), Noncash 0 0 19,038,000
Gain (Loss) on Disposition of Property Plant Equipment (232,000) (375,000) (2,638,000)
Other Operating Activities, Cash Flow Statement 7,867,000 7,945,000 7,447,000
Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures:      
Trade accounts receivable (4,858,000) (18,988,000) 21,472,000
Inventories (9,087,000) (40,201,000) 20,659,000
Prepaid expenses and other 6,667,000 (47,000) (5,128,000)
Increase (Decrease) in Other Operating Assets 123,000 (25,000) (874,000)
Trade accounts payable (13,964,000) 12,681,000 10,343,000
Accrued liabilities 9,150,000 696,000 (3,174,000)
Increase (Decrease) in Other Noncurrent Liabilities (13,689,000) (11,211,000) (7,632,000)
Net cash provided by (used for) operating activities 83,636,000 48,881,000 98,890,000
Proceeds from Sale and Maturity of Marketable Securities 3,651,000 4,434,000 5,111,000
Investing activities:      
Capital expenditures (12,632,000) (13,104,000) (12,300,000)
Proceeds from Sales of Assets, Investing Activities 373,000 461,000 5,453,000
Proceeds from Insurance Settlement, Investing Activities 0 482,000 100,000
Proceeds from Equity Method Investment, Distribution, Return of Capital 313,000 324,000 587,000
Proceeds from Sale of Property, Plant, and Equipment 0 0 446,000
Payments to Acquire Restricted Investments (1,616,000) (539,778,000) 0
Net Cash Provided by (Used in) Investing Activities (13,932,000) (554,311,000) (5,548,000)
Financing activities:      
Proceeds from issuance of common stock 713,000 2,655,000 1,973,000
Proceeds from (Repayments of) Debt, Maturing in More than Three Months 0 0 25,000,000
Repayments of Lines of Credit 0 0 (25,000,000)
Payments for Repurchase of Common Stock (1,001,000) 0 0
Payments of Dividends (8,008,000) (6,562,000) (5,733,000)
Repayment of debt (40,550,000) (477,846,000) (4,450,000)
Payments of Financing Costs 0 0 (826,000)
Proceeds from Issuance of Long-term Debt 0 725,000,000 0
Proceeds from Issuance or Sale of Equity 0 207,000,000 0
Debt Related Commitment Fees and Debt Issuance Costs 0 (26,184,000) 0
Proceeds from Derivative Instrument, Financing Activities 24,495,000 19,417,000 0
Payments for Derivative Instrument, Financing Activities (24,221,000) (20,206,000) 0
Other (1,415,000) (2,574,000) (1,153,000)
Net cash provided by (used for) financing activities (49,987,000) 420,700,000 (10,189,000)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations (1,931,000) (2,007,000) 4,524,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17,786,000 (86,737,000) 87,677,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 133,426,000 115,640,000 202,377,000
Supplementary cash flows data:      
Interest Paid, Excluding Capitalized Interest, Operating Activities 26,089,000 18,823,000 9,451,000
Income taxes paid, net of refunds 22,032,000 9,767,000 10,186,000
Property, plant and equipment purchases included in trade accounts payable 624,000 329,000 730,000
Restricted Cash 250,000 250,000 250,000
Payments to Acquire Marketable Securities (4,021,000) (7,130,000) (4,945,000)
Gain (Loss) on Sale of Assets and Asset Impairment Charges $ 175,000 $ 0 $ 0